Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

Show other versions (1)

Background Patients with coronavirus disease 2019 (COVID-19) infections often have macrovascular or microvascular thrombosis and inflammation, which are known to be associated with a poor prognosis. Heparin has been hypothesized that administration of heparin with treatment dose rather than prophyla...

Full description

Bibliographic Details
Main Authors: Hyeon-Jeong Lee, Hye Jin Jang, Won-Il Choi, Joonsung Joh, Junghyun Kim, Jungeun Park, Miyoung Choi
Format: Article
Language:English
Published: Korean Society of Critical Care Medicine 2023-05-01
Series:Acute and Critical Care
Subjects:
anticoagulants
covid-19
thromboembolism
thrombosis
Online Access:http://www.accjournal.org/upload/pdf/acc-2022-01424.pdf

Internet

http://www.accjournal.org/upload/pdf/acc-2022-01424.pdf

Similar Items